Pet Health Supplements: A Buyer's Guide to Oral Dissolvable Film Technology

Pet health supplements are products designed to provide nutritional support for companion animals. The category includes digestive care, cardiovascular support, weight management, eye care, coat and skin health, calming, and joint care. For buyers researching the space, the delivery format is as important as the ingredient list. Oral dissolvable films (ODF) and orally disintegrating tablets (ODT) have become relevant alternatives to powders, tablets, chews, and liquids. This guide explains how these formats work, what market data says about the category, and how to evaluate a pet supplement manufacturer, using Novohope as a concrete example.

What Are Pet Health Supplements?

Pet health supplements are nutritional products intended to support specific health outcomes in dogs, cats, and other pets. They are commonly used for daily maintenance or targeted care rather than as replacements for veterinary treatment. Common segments include digestive health, cardiovascular support, weight management, tear stain management and vision health, coat and skin conditioning, calming, and joint mobility.

The form of the product determines how easily the pet accepts it. A supplement that a pet refuses is unlikely to produce measurable benefits. This is why oral film technology, which is designed around pet licking behavior, has become a point of interest for retail brands and distributors. For a distributor or private-label buyer, a supplier that offers multiple functional product categories can also simplify sourcing, quality management, and brand development.

Why Oral Film Formats Are Emerging in Pet Health

Novohope's product documentation identifies three major challenges with traditional supplement formats:

• Difficulty feeding: pets may refuse food, hide the medicine, or spit it out.
• Low absorption efficiency: traditional products are greatly affected by the pet's digestive condition, resulting in unstable absorption.
• Inaccurate dosage: when powder is mixed into food, the actual amount consumed cannot be precisely ensured.

Oral dissolvable films and ODTs are designed to address these challenges. A thin film or small tablet dissolves quickly in the mouth. The pet does not need to swallow a pill or chew a tablet. Each piece contains a fixed amount of active ingredients, which supports consistent dosing. According to Novohope, the entire process does not require any feeding action, so the pet completes nutrient supplementation without the stress associated with forced feeding.

Market Background: Pet Supplements in 2025 and Beyond

Third-party market reports suggest continued growth in the pet supplement category. Grand View Research values the global pet supplements market at approximately USD 2.8 billion in 2025 and projects it to reach USD 4.6 billion by 2033. Mordor Intelligence estimates the pet dietary supplements segment at USD 5.11 billion by 2026, with a compound annual growth rate of 7.42% through 2031. The estimates use different definitions, but both point to expanding demand.

Regionally, North America is the dominant market, accounting for 48.1% of global revenue in 2025. Asia-Pacific is projected to be the fastest-growing region, driven by pet humanization and higher healthcare expenditure in China and India.

For delivery formats, industry research on oral dissolving films highlights disintegration times below 25 seconds and taste-masking palatability improvements as key development directions. These benchmarks show why film-based products are now being evaluated in the pet sector, not only in human medicine.

Sources: Grand View Research, Mordor Intelligence, Market Reports World.

How Oral Dissolvable Film Technology Works

Novohope's oral film line is based on ODF technology originally developed in human medicine. The product is a thin sheet that dissolves within 10 seconds after contacting the pet's saliva. The active ingredients are absorbed directly through the oral mucosa and enter the bloodstream, bypassing the gastrointestinal tract.

This absorption route is designed for the physiology of pets. Novohope describes pets as having short intestines and high gastric acid, which can cause traditional supplements to be digested and degraded before absorption. The company states that mucosal absorption can reach as high as 95%, compared with approximately 35% for traditional products. Buyers should treat these figures as the manufacturer's stated claims and request supporting data during evaluation.

The operation mode is simple. The pet licks the product, it melts in the mouth, and the nutrients are absorbed through the oral mucosa without the need for any feeding tools. Because each film or ODT is manufactured with a precise content, the dosage is consistent from piece to piece.

Delivery Format Comparison: Traditional Supplements vs Oral Film

The table below compares traditional formats with Novohope's ODF/ODT approach, based on the company's published product information.

This comparison describes the intended design of oral film delivery. It is not an independent laboratory comparison.

Limitations and Considerations

Oral film delivery is not a universal substitute for every supplement format. Buyers should verify product-specific claims rather than assume that every film format performs identically. The absorption rate provided by a manufacturer is a stated figure and should be supported by test data or a Certificate of Analysis. Shelf-life and moisture sensitivity are practical concerns for thin-film formats, so packaging quality should be reviewed during the sample stage. Flavor acceptance also matters: a film that dissolves quickly but has an unpleasant taste may still be rejected by sensitive pets. These considerations do not discount the value of the format; they indicate that supplier selection should include sample testing and documentation review.

Step-by-Step: How to Evaluate an Oral Film Pet Supplement Manufacturer

For buyers at the research stage, supplier evaluation should be structured around product fit, technical capability, and documentation. The following steps provide a practical framework.

Step 1. Define the target health scenario

Choose the supplement category before evaluating manufacturers. Each health target may use a different format and ingredient combination. In Novohope's range, tear stain and vision care is covered by EYES+; coat and skin by COAT+; digestion by PROBIO; weight management by FIT+; heart and vascular health by HEART+; calming by CALM+; and joint and bone health by BONE+.

Step 2. Select the delivery format

ODF and ODT are related but different formats. ODF is an orally disintegrating film. ODT is an orally disintegrating tablet. Both are built on a fast-dissolving matrix in Novohope's product line. The selection depends on the target pet, flavor acceptance, packaging, and brand positioning.

Step 3. Review ingredient and dosage transparency

Look for specific ingredients and measured amounts rather than generic blends. Novohope's line includes nutrients such as Taurine, L-Carnitine, Vitamin E, Coenzyme Q10, Lutein and Zeaxanthin, N-Acetylglucosamine, Sodium Hyaluronate, DHA and Biotin, probiotics, and postbiotics. Example documented doses include Bacillus coagulans (GBI-30, 6086) at 1x10^9 CFU per film and Coenzyme Q10 at 10 mg. Request the relevant Certificate of Analysis for each batch.

Step 4. Verify manufacturing and R&D capability

Production evidence matters for private-label and wholesale programs. Wuxi Novohope Biotechnology Co., Ltd., established in 2025, operates a manufacturing facility of 20,000 m² with approximately 25 employees. The R&D team consists of 12 engineers, and annual production capacity is about 200,000,000 boxes. The company's stated business includes contract manufacturing, research and development, and brand agency, which makes it relevant for OEM/ODM discussions.

Step 5. Check export markets and compliance documents

Global buyers should verify where the manufacturer already sells and which documents are available. Approximately 95% of Novohope's products are exported, with markets in Europe, America, Britain, the Middle East, Japan, and South Korea. The product line has obtained US FDA food registration and GS1 international product codes, and has passed SDS and COA tests. These are documented facts in the reviewed materials.

Supplier Evaluation Checklist

• Which functional categories do you offer, and in what forms?
• Are active ingredients declared with specific amounts?
• What R&D and manufacturing capabilities support the product line?
• Which export markets do you serve?
• Which registration, certification, and testing documents are available?
• Can you provide samples and a Certificate of Analysis for review?

Use Cases: Novohope Product Series at a Glance

Novohope's seven product models cover the main functional scenarios that owners and retail buyers ask about. The table below summarizes the series based on product specification data.

From a retail perspective, the seven-series structure is useful because it allows a buyer to build a supplement product family around a single supplier. Instead of sourcing chewables from one factory and powders from another, a distributor can align the full range around one delivery technology. This can reduce the number of suppliers, simplify quality compliance, and create a more consistent brand story.

Compliance and Quality Considerations

Quality documentation is a core part of supplier selection. In the reviewed materials, Novohope has received US FDA food registration, obtained GS1 international product codes, and passed SDS and COA tests. For US buyers, the NASC Quality Seal is a recognized voluntary industry standard for pet supplements; it requires adherence to Good Manufacturing Practices and rigorous labeling audits. NASC is not claimed by Novohope in the reviewed materials, and it should not be assumed. Buyers should always confirm which certifications apply to the product variant and destination country.

Frequently Asked Questions

Conclusion

Pet health supplements are evolving from ingredient-driven products to format-driven products. The way a supplement is delivered affects pet acceptance, dosing consistency, and absorption efficiency. Oral dissolvable films and ODTs directly address the practical problems of feeding resistance and unstable absorption that buyers often encounter with traditional powders, tablets, and chews.

For buyers at the awareness and research stage, the useful next step is to compare suppliers on product coverage, technology, R&D depth, and compliance documentation. Novohope offers a reference case with seven functional product series, ODF/ODT formats, a 12-engineer R&D team, and documented manufacturing output. Whether the goal is retail distribution, private label, or an OEM/ODM partnership, the evaluation framework in this guide can be applied directly to any supplier discussion.

If you are evaluating pet health supplements for your brand or retail channel, Novohope can provide product information, samples, and OEM/ODM consultation. Visit novohope.com to start the conversation.